img

Global Postoperative Nausea and Vomiting Management Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Postoperative Nausea and Vomiting Management Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Postoperative nausea and vomiting (PONV) management refers to the various strategies and interventions used to prevent or treat nausea and vomiting in patients after surgery.
Postoperative Nausea and Vomiting Management report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Postoperative Nausea and Vomiting Management market is projected to reach US$ 2346.5 million in 2033, increasing from US$ 1040 million in 2022, with the CAGR of 12.3% during the period of 2023 to 2033. Demand from Hospital Pharmacies and Online Pharmacies are the major drivers for the industry.
The postoperative nausea and vomiting (PONV) management market is driven by the increasing number of surgical procedures and the growing awareness about the adverse effects of PONV on patients' recovery and satisfaction. Anesthesia-induced nausea and vomiting are common complications after surgery, and effective PONV management is crucial to enhance patient outcomes and reduce healthcare costs associated with extended hospital stays and additional treatments. As a result, there is a rising demand for pharmacological and non-pharmacological interventions, such as antiemetic medications, acupressure, and enhanced recovery protocols, to prevent and alleviate PONV. However, the market also faces challenges, including the variability in individual patient responses to antiemetic treatments and the risk of adverse effects associated with certain medications. Additionally, the availability and affordability of effective PONV management options in different healthcare settings can vary, especially in resource-limited regions. Overcoming these challenges through ongoing research and innovation in PONV management approaches, personalized patient care, and education of healthcare professionals will be essential in driving the growth of the postoperative nausea and vomiting management market and improving the post-surgical experience for patients worldwide.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Postoperative Nausea and Vomiting Management market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Acacia Pharma
Roche
Novartis AG
Ani Pharmaceuticals, Inc
Camurus AB
Sanofi S.A.
Helsinn Holding S.A.
Eisai Corporation
Merck and Co.
GlaxoSmithKline
Segment by Type
Serotonin Antagonists
Steroids
Dopamine Antagonists
Neurokinin NK-1 Receptor Antagonists
Non-pharmacological Treatment

Segment by Application


Hospital Pharmacies
Online Pharmacies
Retail Pharmacies and Drug Stores
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Postoperative Nausea and Vomiting Management market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Postoperative Nausea and Vomiting Management introduction, etc. Postoperative Nausea and Vomiting Management Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Postoperative Nausea and Vomiting Management market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of Postoperative Nausea and Vomiting Management
1.1 Postoperative Nausea and Vomiting Management Market Overview
1.1.1 Postoperative Nausea and Vomiting Management Product Scope
1.1.2 Postoperative Nausea and Vomiting Management Market Status and Outlook
1.2 Global Postoperative Nausea and Vomiting Management Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Postoperative Nausea and Vomiting Management Market Size by Region (2018-2033)
1.4 Global Postoperative Nausea and Vomiting Management Historic Market Size by Region (2018-2023)
1.5 Global Postoperative Nausea and Vomiting Management Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Postoperative Nausea and Vomiting Management Market Size (2018-2033)
1.6.1 North America Postoperative Nausea and Vomiting Management Market Size (2018-2033)
1.6.2 Europe Postoperative Nausea and Vomiting Management Market Size (2018-2033)
1.6.3 Asia-Pacific Postoperative Nausea and Vomiting Management Market Size (2018-2033)
1.6.4 Latin America Postoperative Nausea and Vomiting Management Market Size (2018-2033)
1.6.5 Middle East & Africa Postoperative Nausea and Vomiting Management Market Size (2018-2033)
2 Postoperative Nausea and Vomiting Management Market by Type
2.1 Introduction
2.1.1 Serotonin Antagonists
2.1.2 Steroids
2.1.3 Dopamine Antagonists
2.1.4 Neurokinin NK-1 Receptor Antagonists
2.1.5 Non-pharmacological Treatment
2.2 Global Postoperative Nausea and Vomiting Management Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Postoperative Nausea and Vomiting Management Historic Market Size by Type (2018-2023)
2.2.2 Global Postoperative Nausea and Vomiting Management Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Postoperative Nausea and Vomiting Management Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Postoperative Nausea and Vomiting Management Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Postoperative Nausea and Vomiting Management Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Postoperative Nausea and Vomiting Management Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Postoperative Nausea and Vomiting Management Revenue Breakdown by Type (2018-2033)
3 Postoperative Nausea and Vomiting Management Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Online Pharmacies
3.1.3 Retail Pharmacies and Drug Stores
3.2 Global Postoperative Nausea and Vomiting Management Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Postoperative Nausea and Vomiting Management Historic Market Size by Application (2018-2023)
3.2.2 Global Postoperative Nausea and Vomiting Management Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Postoperative Nausea and Vomiting Management Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Postoperative Nausea and Vomiting Management Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Postoperative Nausea and Vomiting Management Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Postoperative Nausea and Vomiting Management Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Postoperative Nausea and Vomiting Management Revenue Breakdown by Application (2018-2033)
4 Postoperative Nausea and Vomiting Management Competition Analysis by Players
4.1 Global Postoperative Nausea and Vomiting Management Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Postoperative Nausea and Vomiting Management as of 2022)
4.3 Date of Key Players Enter into Postoperative Nausea and Vomiting Management Market
4.4 Global Top Players Postoperative Nausea and Vomiting Management Headquarters and Area Served
4.5 Key Players Postoperative Nausea and Vomiting Management Product Solution and Service
4.6 Competitive Status
4.6.1 Postoperative Nausea and Vomiting Management Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Acacia Pharma
5.1.1 Acacia Pharma Profile
5.1.2 Acacia Pharma Main Business
5.1.3 Acacia Pharma Postoperative Nausea and Vomiting Management Products, Services and Solutions
5.1.4 Acacia Pharma Postoperative Nausea and Vomiting Management Revenue (US$ Million) & (2018-2023)
5.1.5 Acacia Pharma Recent Developments
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business
5.2.3 Roche Postoperative Nausea and Vomiting Management Products, Services and Solutions
5.2.4 Roche Postoperative Nausea and Vomiting Management Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Recent Developments
5.3 Novartis AG
5.3.1 Novartis AG Profile
5.3.2 Novartis AG Main Business
5.3.3 Novartis AG Postoperative Nausea and Vomiting Management Products, Services and Solutions
5.3.4 Novartis AG Postoperative Nausea and Vomiting Management Revenue (US$ Million) & (2018-2023)
5.3.5 Ani Pharmaceuticals, Inc Recent Developments
5.4 Ani Pharmaceuticals, Inc
5.4.1 Ani Pharmaceuticals, Inc Profile
5.4.2 Ani Pharmaceuticals, Inc Main Business
5.4.3 Ani Pharmaceuticals, Inc Postoperative Nausea and Vomiting Management Products, Services and Solutions
5.4.4 Ani Pharmaceuticals, Inc Postoperative Nausea and Vomiting Management Revenue (US$ Million) & (2018-2023)
5.4.5 Ani Pharmaceuticals, Inc Recent Developments
5.5 Camurus AB
5.5.1 Camurus AB Profile
5.5.2 Camurus AB Main Business
5.5.3 Camurus AB Postoperative Nausea and Vomiting Management Products, Services and Solutions
5.5.4 Camurus AB Postoperative Nausea and Vomiting Management Revenue (US$ Million) & (2018-2023)
5.5.5 Camurus AB Recent Developments
5.6 Sanofi S.A.
5.6.1 Sanofi S.A. Profile
5.6.2 Sanofi S.A. Main Business
5.6.3 Sanofi S.A. Postoperative Nausea and Vomiting Management Products, Services and Solutions
5.6.4 Sanofi S.A. Postoperative Nausea and Vomiting Management Revenue (US$ Million) & (2018-2023)
5.6.5 Sanofi S.A. Recent Developments
5.7 Helsinn Holding S.A.
5.7.1 Helsinn Holding S.A. Profile
5.7.2 Helsinn Holding S.A. Main Business
5.7.3 Helsinn Holding S.A. Postoperative Nausea and Vomiting Management Products, Services and Solutions
5.7.4 Helsinn Holding S.A. Postoperative Nausea and Vomiting Management Revenue (US$ Million) & (2018-2023)
5.7.5 Helsinn Holding S.A. Recent Developments
5.8 Eisai Corporation
5.8.1 Eisai Corporation Profile
5.8.2 Eisai Corporation Main Business
5.8.3 Eisai Corporation Postoperative Nausea and Vomiting Management Products, Services and Solutions
5.8.4 Eisai Corporation Postoperative Nausea and Vomiting Management Revenue (US$ Million) & (2018-2023)
5.8.5 Eisai Corporation Recent Developments
5.9 Merck and Co.
5.9.1 Merck and Co. Profile
5.9.2 Merck and Co. Main Business
5.9.3 Merck and Co. Postoperative Nausea and Vomiting Management Products, Services and Solutions
5.9.4 Merck and Co. Postoperative Nausea and Vomiting Management Revenue (US$ Million) & (2018-2023)
5.9.5 Merck and Co. Recent Developments
5.10 GlaxoSmithKline
5.10.1 GlaxoSmithKline Profile
5.10.2 GlaxoSmithKline Main Business
5.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting Management Products, Services and Solutions
5.10.4 GlaxoSmithKline Postoperative Nausea and Vomiting Management Revenue (US$ Million) & (2018-2023)
5.10.5 GlaxoSmithKline Recent Developments
6 North America
6.1 North America Postoperative Nausea and Vomiting Management Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Postoperative Nausea and Vomiting Management Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Postoperative Nausea and Vomiting Management Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Postoperative Nausea and Vomiting Management Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Postoperative Nausea and Vomiting Management Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Postoperative Nausea and Vomiting Management Market Dynamics
11.1 Postoperative Nausea and Vomiting Management Industry Trends
11.2 Postoperative Nausea and Vomiting Management Market Drivers
11.3 Postoperative Nausea and Vomiting Management Market Challenges
11.4 Postoperative Nausea and Vomiting Management Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Postoperative Nausea and Vomiting Management Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Postoperative Nausea and Vomiting Management Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Postoperative Nausea and Vomiting Management Market Size Share by Region (2018-2023)
Table 4. Global Postoperative Nausea and Vomiting Management Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Postoperative Nausea and Vomiting Management Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Postoperative Nausea and Vomiting Management Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Postoperative Nausea and Vomiting Management Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Postoperative Nausea and Vomiting Management Revenue Market Share by Type (2018-2023)
Table 9. Global Postoperative Nausea and Vomiting Management Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Postoperative Nausea and Vomiting Management Revenue Market Share by Type (2024-2033)
Table 11. North America Postoperative Nausea and Vomiting Management Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Postoperative Nausea and Vomiting Management Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Postoperative Nausea and Vomiting Management Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Postoperative Nausea and Vomiting Management Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Postoperative Nausea and Vomiting Management Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Postoperative Nausea and Vomiting Management Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Postoperative Nausea and Vomiting Management Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Postoperative Nausea and Vomiting Management Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Postoperative Nausea and Vomiting Management Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Postoperative Nausea and Vomiting Management Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Postoperative Nausea and Vomiting Management Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Postoperative Nausea and Vomiting Management Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Postoperative Nausea and Vomiting Management Revenue Market Share by Application (2018-2023)
Table 24. Global Postoperative Nausea and Vomiting Management Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Postoperative Nausea and Vomiting Management Revenue Market Share by Application (2024-2033)
Table 26. North America Postoperative Nausea and Vomiting Management Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Postoperative Nausea and Vomiting Management Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Postoperative Nausea and Vomiting Management Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Postoperative Nausea and Vomiting Management Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Postoperative Nausea and Vomiting Management Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Postoperative Nausea and Vomiting Management Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Postoperative Nausea and Vomiting Management Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Postoperative Nausea and Vomiting Management Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Postoperative Nausea and Vomiting Management Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Postoperative Nausea and Vomiting Management Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Postoperative Nausea and Vomiting Management Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Postoperative Nausea and Vomiting Management Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Postoperative Nausea and Vomiting Management as of 2022)
Table 39. Date of Key Players Enter into Postoperative Nausea and Vomiting Management Market
Table 40. Global Postoperative Nausea and Vomiting Management Key Players Headquarters and Area Served
Table 41. Postoperative Nausea and Vomiting Management Product Solution and Service
Table 42. Global Postoperative Nausea and Vomiting Management Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Acacia Pharma Basic Information List
Table 45. Acacia Pharma Description and Business Overview
Table 46. Acacia Pharma Postoperative Nausea and Vomiting Management Products, Services and Solutions
Table 47. Revenue (US$ Million) in Postoperative Nausea and Vomiting Management Business of Acacia Pharma (2018-2023)
Table 48. Acacia Pharma Recent Developments
Table 49. Roche Basic Information List
Table 50. Roche Description and Business Overview
Table 51. Roche Postoperative Nausea and Vomiting Management Products, Services and Solutions
Table 52. Revenue (US$ Million) in Postoperative Nausea and Vomiting Management Business of Roche (2018-2023)
Table 53. Roche Recent Developments
Table 54. Novartis AG Basic Information List
Table 55. Novartis AG Description and Business Overview
Table 56. Novartis AG Postoperative Nausea and Vomiting Management Products, Services and Solutions
Table 57. Revenue (US$ Million) in Postoperative Nausea and Vomiting Management Business of Novartis AG (2018-2023)
Table 58. Novartis AG Recent Developments
Table 59. Ani Pharmaceuticals, Inc Basic Information List
Table 60. Ani Pharmaceuticals, Inc Description and Business Overview
Table 61. Ani Pharmaceuticals, Inc Postoperative Nausea and Vomiting Management Products, Services and Solutions
Table 62. Revenue (US$ Million) in Postoperative Nausea and Vomiting Management Business of Ani Pharmaceuticals, Inc (2018-2023)
Table 63. Ani Pharmaceuticals, Inc Recent Developments
Table 64. Camurus AB Basic Information List
Table 65. Camurus AB Description and Business Overview
Table 66. Camurus AB Postoperative Nausea and Vomiting Management Products, Services and Solutions
Table 67. Revenue (US$ Million) in Postoperative Nausea and Vomiting Management Business of Camurus AB (2018-2023)
Table 68. Camurus AB Recent Developments
Table 69. Sanofi S.A. Basic Information List
Table 70. Sanofi S.A. Description and Business Overview
Table 71. Sanofi S.A. Postoperative Nausea and Vomiting Management Products, Services and Solutions
Table 72. Revenue (US$ Million) in Postoperative Nausea and Vomiting Management Business of Sanofi S.A. (2018-2023)
Table 73. Sanofi S.A. Recent Developments
Table 74. Helsinn Holding S.A. Basic Information List
Table 75. Helsinn Holding S.A. Description and Business Overview
Table 76. Helsinn Holding S.A. Postoperative Nausea and Vomiting Management Products, Services and Solutions
Table 77. Revenue (US$ Million) in Postoperative Nausea and Vomiting Management Business of Helsinn Holding S.A. (2018-2023)
Table 78. Helsinn Holding S.A. Recent Developments
Table 79. Eisai Corporation Basic Information List
Table 80. Eisai Corporation Description and Business Overview
Table 81. Eisai Corporation Postoperative Nausea and Vomiting Management Products, Services and Solutions
Table 82. Revenue (US$ Million) in Postoperative Nausea and Vomiting Management Business of Eisai Corporation (2018-2023)
Table 83. Eisai Corporation Recent Developments
Table 84. Merck and Co. Basic Information List
Table 85. Merck and Co. Description and Business Overview
Table 86. Merck and Co. Postoperative Nausea and Vomiting Management Products, Services and Solutions
Table 87. Revenue (US$ Million) in Postoperative Nausea and Vomiting Management Business of Merck and Co. (2018-2023)
Table 88. Merck and Co. Recent Developments
Table 89. GlaxoSmithKline Basic Information List
Table 90. GlaxoSmithKline Description and Business Overview
Table 91. GlaxoSmithKline Postoperative Nausea and Vomiting Management Products, Services and Solutions
Table 92. Revenue (US$ Million) in Postoperative Nausea and Vomiting Management Business of GlaxoSmithKline (2018-2023)
Table 93. GlaxoSmithKline Recent Developments
Table 94. North America Postoperative Nausea and Vomiting Management Market Size by Country (2018-2023) & (US$ Million)
Table 95. North America Postoperative Nausea and Vomiting Management Market Size by Country (2024-2033) & (US$ Million)
Table 96. Europe Postoperative Nausea and Vomiting Management Market Size by Country (2018-2023) & (US$ Million)
Table 97. Europe Postoperative Nausea and Vomiting Management Market Size by Country (2024-2033) & (US$ Million)
Table 98. Asia-Pacific Postoperative Nausea and Vomiting Management Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 99. Asia-Pacific Postoperative Nausea and Vomiting Management Market Size by Region (2018-2023) & (US$ Million)
Table 100. Asia-Pacific Postoperative Nausea and Vomiting Management Market Size by Region (2024-2033) & (US$ Million)
Table 101. Asia-Pacific Postoperative Nausea and Vomiting Management Market Share by Region (2018-2023)
Table 102. Asia-Pacific Postoperative Nausea and Vomiting Management Market Share by Region (2024-2033)
Table 103. Latin America Postoperative Nausea and Vomiting Management Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 104. Latin America Postoperative Nausea and Vomiting Management Market Size by Country (2018-2023) & (US$ Million)
Table 105. Latin America Postoperative Nausea and Vomiting Management Market Size by Country (2024-2033) & (US$ Million)
Table 106. Middle East & Africa Postoperative Nausea and Vomiting Management Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 107. Middle East & Africa Postoperative Nausea and Vomiting Management Market Size by Country (2018-2023) & (US$ Million)
Table 108. Middle East & Africa Postoperative Nausea and Vomiting Management Market Size by Country (2024-2033) & (US$ Million)
Table 109. Postoperative Nausea and Vomiting Management Market Trends
Table 110. Postoperative Nausea and Vomiting Management Market Drivers
Table 111. Postoperative Nausea and Vomiting Management Market Challenges
Table 112. Postoperative Nausea and Vomiting Management Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Postoperative Nausea and Vomiting Management Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Postoperative Nausea and Vomiting Management Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Postoperative Nausea and Vomiting Management Market Share by Regions: 2022 VS 2033
Figure 4. Global Postoperative Nausea and Vomiting Management Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Postoperative Nausea and Vomiting Management Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Postoperative Nausea and Vomiting Management Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Postoperative Nausea and Vomiting Management Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Postoperative Nausea and Vomiting Management Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Postoperative Nausea and Vomiting Management Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Serotonin Antagonists
Figure 11. Global Serotonin Antagonists Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Steroids
Figure 13. Global Steroids Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of Dopamine Antagonists
Figure 15. Global Dopamine Antagonists Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Product Picture of Neurokinin NK-1 Receptor Antagonists
Figure 17. Global Neurokinin NK-1 Receptor Antagonists Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 18. Product Picture of Non-pharmacological Treatment
Figure 19. Global Non-pharmacological Treatment Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 20. Global Postoperative Nausea and Vomiting Management Market Size Share by Type: 2022 & 2033
Figure 21. North America Postoperative Nausea and Vomiting Management Revenue Market Share by Type (2018-2033)
Figure 22. Europe Postoperative Nausea and Vomiting Management Revenue Market Share by Type (2018-2033)
Figure 23. Asia-Pacific Postoperative Nausea and Vomiting Management Revenue Market Share by Type (2018-2033)
Figure 24. Latin America Postoperative Nausea and Vomiting Management Revenue Market Share by Type (2018-2033)
Figure 25. Middle East and Africa Postoperative Nausea and Vomiting Management Revenue Market Share by Type (2018-2033)
Figure 26. Hospital Pharmacies Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 27. Online Pharmacies Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 28. Retail Pharmacies and Drug Stores Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 29. Global Postoperative Nausea and Vomiting Management Market Size Share by Application: 2022 & 2033
Figure 30. North America Postoperative Nausea and Vomiting Management Revenue Market Share by Application (2018-2033)
Figure 31. Europe Postoperative Nausea and Vomiting Management Revenue Market Share by Application (2018-2033)
Figure 32. Asia-Pacific Postoperative Nausea and Vomiting Management Revenue Market Share by Application (2018-2033)
Figure 33. Latin America Postoperative Nausea and Vomiting Management Revenue Market Share by Application (2018-2033)
Figure 34. Middle East and Africa Postoperative Nausea and Vomiting Management Revenue Market Share by Application (2018-2033)
Figure 35. Postoperative Nausea and Vomiting Management Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 36. Global Top 5 and Top 10 Players Postoperative Nausea and Vomiting Management Market Share in 2022
Figure 37. North America Postoperative Nausea and Vomiting Management Market Share by Country (2018-2033)
Figure 38. United States Postoperative Nausea and Vomiting Management Market Size (2018-2033) & (US$ Million)
Figure 39. Canada Postoperative Nausea and Vomiting Management Market Size (2018-2033) & (US$ Million)
Figure 40. Germany Postoperative Nausea and Vomiting Management Market Size (2018-2033) & (US$ Million)
Figure 41. France Postoperative Nausea and Vomiting Management Market Size (2018-2033) & (US$ Million)
Figure 42. U.K. Postoperative Nausea and Vomiting Management Market Size (2018-2033) & (US$ Million)
Figure 43. Italy Postoperative Nausea and Vomiting Management Market Size (2018-2033) & (US$ Million)
Figure 44. Russia Postoperative Nausea and Vomiting Management Market Size (2018-2033) & (US$ Million)
Figure 45. Nordic Countries Postoperative Nausea and Vomiting Management Market Size (2018-2033) & (US$ Million)
Figure 46. Asia-Pacific Postoperative Nausea and Vomiting Management Market Share by Region (2018-2033)
Figure 47. China Postoperative Nausea and Vomiting Management Market Size (2018-2033) & (US$ Million)
Figure 48. Japan Postoperative Nausea and Vomiting Management Market Size (2018-2033) & (US$ Million)
Figure 49. South Korea Postoperative Nausea and Vomiting Management Market Size (2018-2033) & (US$ Million)
Figure 50. Southeast Asia Postoperative Nausea and Vomiting Management Market Size (2018-2033) & (US$ Million)
Figure 51. India Postoperative Nausea and Vomiting Management Market Size (2018-2033) & (US$ Million)
Figure 52. Australia Postoperative Nausea and Vomiting Management Market Size (2018-2033) & (US$ Million)
Figure 53. Latin America Postoperative Nausea and Vomiting Management Market Share by Country (2018-2033)
Figure 54. Mexico Postoperative Nausea and Vomiting Management Market Size (2018-2033) & (US$ Million)
Figure 55. Brazil Postoperative Nausea and Vomiting Management Market Size (2018-2033) & (US$ Million)
Figure 56. Middle East & Africa Postoperative Nausea and Vomiting Management Market Share by Country (2018-2033)
Figure 57. Turkey Postoperative Nausea and Vomiting Management Market Size (2018-2033) & (US$ Million)
Figure 58. Saudi Arabia Postoperative Nausea and Vomiting Management Market Size (2018-2033) & (US$ Million)
Figure 59. UAE Postoperative Nausea and Vomiting Management Market Size (2018-2033) & (US$ Million)
Figure 60. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries